EXANE DERIVATIVES - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$404,000
-98.9%
8
-98.6%
0.00%
-100.0%
Q1 2022$36,218,000
-13.1%
567
+45.8%
0.01%0.0%
Q4 2021$41,664,000
+1400.9%
389
+1340.7%
0.01%
+900.0%
Q3 2021$2,776,000
+24.4%
270.0%0.00%0.0%
Q2 2021$2,232,000
-15.0%
270.0%0.00%0.0%
Q1 2021$2,625,000
-13.3%
270.0%0.00%0.0%
Q4 2020$3,028,000
+21.0%
270.0%0.00%0.0%
Q3 2020$2,503,000
+18.9%
270.0%0.00%0.0%
Q2 2020$2,106,000
-98.0%
27
-98.5%
0.00%
-96.6%
Q1 2020$103,505,000
+25711.7%
1,770
+35300.0%
0.03%
Q4 2019$401,000
+9.3%
50.0%0.00%
Q3 2019$367,000
-22.1%
50.0%0.00%
Q2 2019$471,000
-93.8%
5
-94.7%
0.00%
-100.0%
Q1 2019$7,602,000
+984.5%
95
+630.8%
0.00%
Q4 2018$701,000
-31.4%
130.0%0.00%
Q3 2018$1,022,000
-98.9%
13
-99.1%
0.00%
-100.0%
Q2 2018$90,708,000
-28.5%
1,4620.0%0.02%
-40.0%
Q1 2018$126,809,0001,4620.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders